 | • レポートコード：MRC2012A3451 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、勃起不全治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。勃起不全治療薬の種類別市場規模（シルデナフィル、タダラフィル、その他）、用途別市場規模（病院薬局、民間クリニック、小売薬局、Eコマース（B2B）、Eコマース（B2C））、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Eli Lilly、Metuchen Pharma、BaiYunShan General Factory、Pfizer、Dong-A ST、Bayer、CSBIO.、Teva Pharma、S.K. Chemicals、Seoul Pharma、 ・地域別グローバル市場分析 2015年-2020年 ・勃起不全治療薬の北米市場（アメリカ、カナダ、メキシコ） ・勃起不全治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・勃起不全治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・勃起不全治療薬の南米市場（ブラジル、アルゼンチン） ・勃起不全治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：シルデナフィル、タダラフィル、その他 ・用途別分析：病院薬局、民間クリニック、小売薬局、Eコマース（B2B）、Eコマース（B2C） ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Erectile Dysfunction Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Erectile Dysfunction Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.7%% in the forecast period of 2020 to 2025 and will expected to reach USD 6915.4 million by 2025, from USD 5531.3 million in 2019.
Market segmentation
Erectile Dysfunction Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Erectile Dysfunction Drugs market has been segmented into
Sildenafil
Tadalafil
Others
By Application, Erectile Dysfunction Drugs has been segmented into:
Hospital Pharmacies
Private Clinics
Retail Pharmacies
E-Commerce (B2B)
E-Commerce (B2C)
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Erectile Dysfunction Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Erectile Dysfunction Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Erectile Dysfunction Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Erectile Dysfunction Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Erectile Dysfunction Drugs Market Share Analysis
Erectile Dysfunction Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Erectile Dysfunction Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Erectile Dysfunction Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Erectile Dysfunction Drugs are:
Eli Lilly
Metuchen Pharma
BaiYunShan General Factory
Pfizer
Dong-A ST
Bayer
CSBIO.
Teva Pharma
S.K. Chemicals
Seoul Pharma
Among other players domestic and global, Erectile Dysfunction Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Erectile Dysfunction Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Erectile Dysfunction Drugs, with price, sales, revenue and global market share of Erectile Dysfunction Drugs in 2018 and 2019.
Chapter 3, the Erectile Dysfunction Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Erectile Dysfunction Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Erectile Dysfunction Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Erectile Dysfunction Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Erectile Dysfunction Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Erectile Dysfunction Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Sildenafil
1.2.3 Tadalafil
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Erectile Dysfunction Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacies
1.3.3 Private Clinics
1.3.4 Retail Pharmacies
1.3.5 E-Commerce (B2B)
1.3.6 E-Commerce (B2C)
1.4 Overview of Global Erectile Dysfunction Drugs Market
1.4.1 Global Erectile Dysfunction Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Eli Lilly
2.1.1 Eli Lilly Details
2.1.2 Eli Lilly Major Business
2.1.3 Eli Lilly SWOT Analysis
2.1.4 Eli Lilly Product and Services
2.1.5 Eli Lilly Erectile Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Metuchen Pharma
2.2.1 Metuchen Pharma Details
2.2.2 Metuchen Pharma Major Business
2.2.3 Metuchen Pharma SWOT Analysis
2.2.4 Metuchen Pharma Product and Services
2.2.5 Metuchen Pharma Erectile Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 BaiYunShan General Factory
2.3.1 BaiYunShan General Factory Details
2.3.2 BaiYunShan General Factory Major Business
2.3.3 BaiYunShan General Factory SWOT Analysis
2.3.4 BaiYunShan General Factory Product and Services
2.3.5 BaiYunShan General Factory Erectile Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer SWOT Analysis
2.4.4 Pfizer Product and Services
2.4.5 Pfizer Erectile Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Dong-A ST
2.5.1 Dong-A ST Details
2.5.2 Dong-A ST Major Business
2.5.3 Dong-A ST SWOT Analysis
2.5.4 Dong-A ST Product and Services
2.5.5 Dong-A ST Erectile Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Bayer
2.6.1 Bayer Details
2.6.2 Bayer Major Business
2.6.3 Bayer Product and Services
2.6.4 Bayer Erectile Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 CSBIO.
2.7.1 CSBIO. Details
2.7.2 CSBIO. Major Business
2.7.3 CSBIO. Product and Services
2.7.4 CSBIO. Erectile Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Teva Pharma
2.8.1 Teva Pharma Details
2.8.2 Teva Pharma Major Business
2.8.3 Teva Pharma Product and Services
2.8.4 Teva Pharma Erectile Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 S.K. Chemicals
2.9.1 S.K. Chemicals Details
2.9.2 S.K. Chemicals Major Business
2.9.3 S.K. Chemicals Product and Services
2.9.4 S.K. Chemicals Erectile Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Seoul Pharma
2.10.1 Seoul Pharma Details
2.10.2 Seoul Pharma Major Business
2.10.3 Seoul Pharma Product and Services
2.10.4 Seoul Pharma Erectile Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Erectile Dysfunction Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Erectile Dysfunction Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Erectile Dysfunction Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Erectile Dysfunction Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Erectile Dysfunction Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Erectile Dysfunction Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Erectile Dysfunction Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
4.5 South America Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Erectile Dysfunction Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Erectile Dysfunction Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Erectile Dysfunction Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Erectile Dysfunction Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Erectile Dysfunction Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Erectile Dysfunction Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
6.3 UK Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
6.4 France Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Erectile Dysfunction Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Erectile Dysfunction Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Erectile Dysfunction Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
7.5 India Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Erectile Dysfunction Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Erectile Dysfunction Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Erectile Dysfunction Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Erectile Dysfunction Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Erectile Dysfunction Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Erectile Dysfunction Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Erectile Dysfunction Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Erectile Dysfunction Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Erectile Dysfunction Drugs Price by Type (2015-2020)
11 Global Erectile Dysfunction Drugs Market Segment by Application
11.1 Global Erectile Dysfunction Drugs Sales Market Share by Application (2015-2020)
11.2 Global Erectile Dysfunction Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Erectile Dysfunction Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Erectile Dysfunction Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Erectile Dysfunction Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Erectile Dysfunction Drugs Market Forecast (2021-2025)
12.2.2 Europe Erectile Dysfunction Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Erectile Dysfunction Drugs Market Forecast (2021-2025)
12.2.4 South America Erectile Dysfunction Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Erectile Dysfunction Drugs Market Forecast (2021-2025)
12.3 Erectile Dysfunction Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Erectile Dysfunction Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Erectile Dysfunction Drugs Market Share Forecast by Type (2021-2025)
12.4 Erectile Dysfunction Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Erectile Dysfunction Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Erectile Dysfunction Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Erectile Dysfunction Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Erectile Dysfunction Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Erectile Dysfunction Drugs Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Erectile Dysfunction Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 9. Eli Lilly Erectile Dysfunction Drugs Major Business
Table 10. Eli Lilly Erectile Dysfunction Drugs Total Revenue (USD Million) (2018-2019)
Table 11. Eli Lilly SWOT Analysis
Table 12. Eli Lilly Erectile Dysfunction Drugs Product and Services
Table 13. Eli Lilly Erectile Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Metuchen Pharma Basic Information, Manufacturing Base and Competitors
Table 15. Metuchen Pharma Erectile Dysfunction Drugs Major Business
Table 16. Metuchen Pharma Erectile Dysfunction Drugs Total Revenue (USD Million) (2018-2019)
Table 17. Metuchen Pharma SWOT Analysis
Table 18. Metuchen Pharma Erectile Dysfunction Drugs Product and Services
Table 19. Metuchen Pharma Erectile Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. BaiYunShan General Factory Basic Information, Manufacturing Base and Competitors
Table 21. BaiYunShan General Factory Erectile Dysfunction Drugs Major Business
Table 22. BaiYunShan General Factory Erectile Dysfunction Drugs Total Revenue (USD Million) (2018-2019)
Table 23. BaiYunShan General Factory SWOT Analysis
Table 24. BaiYunShan General Factory Erectile Dysfunction Drugs Product and Services
Table 25. BaiYunShan General Factory Erectile Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Pfizer Basic Information, Manufacturing Base and Competitors
Table 27. Pfizer Erectile Dysfunction Drugs Major Business
Table 28. Pfizer Erectile Dysfunction Drugs Total Revenue (USD Million) (2018-2019)
Table 29. Pfizer SWOT Analysis
Table 30. Pfizer Erectile Dysfunction Drugs Product and Services
Table 31. Pfizer Erectile Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Dong-A ST Basic Information, Manufacturing Base and Competitors
Table 33. Dong-A ST Erectile Dysfunction Drugs Major Business
Table 34. Dong-A ST Erectile Dysfunction Drugs Total Revenue (USD Million) (2018-2019)
Table 35. Dong-A ST SWOT Analysis
Table 36. Dong-A ST Erectile Dysfunction Drugs Product and Services
Table 37. Dong-A ST Erectile Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Bayer Basic Information, Manufacturing Base and Competitors
Table 39. Bayer Erectile Dysfunction Drugs Major Business
Table 40. Bayer Erectile Dysfunction Drugs Total Revenue (USD Million) (2018-2019)
Table 41. Bayer SWOT Analysis
Table 42. Bayer Erectile Dysfunction Drugs Product and Services
Table 43. Bayer Erectile Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. CSBIO. Basic Information, Manufacturing Base and Competitors
Table 45. CSBIO. Erectile Dysfunction Drugs Major Business
Table 46. CSBIO. Erectile Dysfunction Drugs Total Revenue (USD Million) (2018-2019)
Table 47. CSBIO. SWOT Analysis
Table 48. CSBIO. Erectile Dysfunction Drugs Product and Services
Table 49. CSBIO. Erectile Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Teva Pharma Basic Information, Manufacturing Base and Competitors
Table 51. Teva Pharma Erectile Dysfunction Drugs Major Business
Table 52. Teva Pharma Erectile Dysfunction Drugs Total Revenue (USD Million) (2018-2019)
Table 53. Teva Pharma SWOT Analysis
Table 54. Teva Pharma Erectile Dysfunction Drugs Product and Services
Table 55. Teva Pharma Erectile Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. S.K. Chemicals Basic Information, Manufacturing Base and Competitors
Table 57. S.K. Chemicals Erectile Dysfunction Drugs Major Business
Table 58. S.K. Chemicals Erectile Dysfunction Drugs Total Revenue (USD Million) (2018-2019)
Table 59. S.K. Chemicals SWOT Analysis
Table 60. S.K. Chemicals Erectile Dysfunction Drugs Product and Services
Table 61. S.K. Chemicals Erectile Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Seoul Pharma Basic Information, Manufacturing Base and Competitors
Table 63. Seoul Pharma Erectile Dysfunction Drugs Major Business
Table 64. Seoul Pharma Erectile Dysfunction Drugs Total Revenue (USD Million) (2018-2019)
Table 65. Seoul Pharma SWOT Analysis
Table 66. Seoul Pharma Erectile Dysfunction Drugs Product and Services
Table 67. Seoul Pharma Erectile Dysfunction Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. Global Erectile Dysfunction Drugs Sales by Manufacturer (2018-2019) (M Pill)
Table 69. Global Erectile Dysfunction Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 70. Global Erectile Dysfunction Drugs Sales by Regions (2015-2020) (M Pill)
Table 71. Global Erectile Dysfunction Drugs Sales Market Share by Regions (2015-2020)
Table 72. Global Erectile Dysfunction Drugs Revenue by Regions (2015-2020) (USD Million)
Table 73. North America Erectile Dysfunction Drugs Sales by Countries (2015-2020) (M Pill)
Table 74. North America Erectile Dysfunction Drugs Sales Market Share by Countries (2015-2020)
Table 75. North America Erectile Dysfunction Drugs Revenue by Countries (2015-2020) (USD Million)
Table 76. North America Erectile Dysfunction Drugs Revenue Market Share by Countries (2015-2020)
Table 77. Europe Erectile Dysfunction Drugs Sales by Countries (2015-2020) (M Pill)
Table 78. Europe Erectile Dysfunction Drugs Sales Market Share by Countries (2015-2020)
Table 79. Europe Erectile Dysfunction Drugs Revenue by Countries (2015-2020) (USD Million)
Table 80. Asia-Pacific Erectile Dysfunction Drugs Sales by Regions (2015-2020) (M Pill)
Table 81. Asia-Pacific Erectile Dysfunction Drugs Sales Market Share by Regions (2015-2020)
Table 82. Asia-Pacific Erectile Dysfunction Drugs Revenue by Regions (2015-2020) (USD Million)
Table 83. South America Erectile Dysfunction Drugs Sales by Countries (2015-2020) (M Pill)
Table 84. South America Erectile Dysfunction Drugs Sales Market Share by Countries (2015-2020)
Table 85. South America Erectile Dysfunction Drugs Revenue by Countries (2015-2020) (USD Million)
Table 86. South America Erectile Dysfunction Drugs Revenue Market Share by Countries (2015-2020)
Table 87. Middle East & Africa Erectile Dysfunction Drugs Sales by Countries (2015-2020) (M Pill)
Table 88. Middle East & Africa Erectile Dysfunction Drugs Sales Market Share by Countries (2015-2020)
Table 89. Middle East & Africa Erectile Dysfunction Drugs Revenue by Countries (2015-2020) (USD Million)
Table 90. Middle East & Africa Erectile Dysfunction Drugs Revenue Market Share by Countries (2015-2020)
Table 91. Global Erectile Dysfunction Drugs Sales by Type (2015-2020) (M Pill)
Table 92. Global Erectile Dysfunction Drugs Sales Share by Type (2015-2020)
Table 93. Global Erectile Dysfunction Drugs Revenue by Type (2015-2020) (USD Million)
Table 94. Global Erectile Dysfunction Drugs Revenue Share by Type (2015-2020)
Table 95. Global Erectile Dysfunction Drugs Sales by Application (2015-2020) (M Pill)
Table 96. Global Erectile Dysfunction Drugs Sales Share by Application (2015-2020)
Table 97. Global Erectile Dysfunction Drugs Sales Forecast by Regions (2021-2025) (M Pill)
Table 98. Global Erectile Dysfunction Drugs Market Share Forecast by Regions (2021-2025)
Table 99. Global Erectile Dysfunction Drugs Sales Forecast by Type (2021-2025) (M Pill)
Table 100. Global Erectile Dysfunction Drugs Market Share Forecast by Type (2021-2025)
Table 101. Global Erectile Dysfunction Drugs Sales Forecast by Application (2021-2025)
Table 102. Global Erectile Dysfunction Drugs Market Share Forecast by Application (2021-2025)
Table 103. Direct Channel Pros & Cons
Table 104. Indirect Channel Pros & Cons
Table 105. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Erectile Dysfunction Drugs Picture
Figure 2. Global Sales Market Share of Erectile Dysfunction Drugs by Type in 2019
Figure 3. Sildenafil Picture
Figure 4. Tadalafil Picture
Figure 5. Others Picture
Figure 6. Erectile Dysfunction Drugs Sales Market Share by Application in 2019
Figure 7. Hospital Pharmacies Picture
Figure 8. Private Clinics Picture
Figure 9. Retail Pharmacies Picture
Figure 10. E-Commerce (B2B) Picture
Figure 11. E-Commerce (B2C) Picture
Figure 12. Global Erectile Dysfunction Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Erectile Dysfunction Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Erectile Dysfunction Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Erectile Dysfunction Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Erectile Dysfunction Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Erectile Dysfunction Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Erectile Dysfunction Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Erectile Dysfunction Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Erectile Dysfunction Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Erectile Dysfunction Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Erectile Dysfunction Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Erectile Dysfunction Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Erectile Dysfunction Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Erectile Dysfunction Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Erectile Dysfunction Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Erectile Dysfunction Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Erectile Dysfunction Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Erectile Dysfunction Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Erectile Dysfunction Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Erectile Dysfunction Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Erectile Dysfunction Drugs Sales Market Share by Manufacturer in 2019
Figure 33. Global Erectile Dysfunction Drugs Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Erectile Dysfunction Drugs Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Erectile Dysfunction Drugs Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020) (M Pill)
Figure 38. Global Erectile Dysfunction Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Erectile Dysfunction Drugs Revenue Market Share by Regions (2015-2020)
Figure 40. Global Erectile Dysfunction Drugs Revenue Market Share by Regions in 2018
Figure 41. North America Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
Figure 42. Europe Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
Figure 44. South America Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
Figure 46. North America Erectile Dysfunction Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Erectile Dysfunction Drugs Sales Market Share by Countries (2015-2020)
Figure 48. North America Erectile Dysfunction Drugs Sales Market Share by Countries in 2018
Figure 49. North America Erectile Dysfunction Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Erectile Dysfunction Drugs Revenue Market Share by Countries in 2018
Figure 51. United States Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020) (M Pill)
Figure 52. Canada Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020) (M Pill)
Figure 53. Mexico Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020) (M Pill)
Figure 54. Europe Erectile Dysfunction Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Erectile Dysfunction Drugs Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Erectile Dysfunction Drugs Revenue Market Share by Countries in 2019
Figure 57. Germany Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020) (M Pill)
Figure 58. UK Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020) (M Pill)
Figure 59. France Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020) (M Pill)
Figure 60. Russia Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020) (M Pill)
Figure 61. Italy Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020) (M Pill)
Figure 62. Asia-Pacific Erectile Dysfunction Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Erectile Dysfunction Drugs Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Erectile Dysfunction Drugs Revenue Market Share by Regions 2019
Figure 65. China Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020) (M Pill)
Figure 66. Japan Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020) (M Pill)
Figure 67. Korea Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020) (M Pill)
Figure 68. India Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020) (M Pill)
Figure 69. Southeast Asia Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020) (M Pill)
Figure 70. South America Erectile Dysfunction Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Erectile Dysfunction Drugs Sales Market Share by Countries in 2019
Figure 72. South America Erectile Dysfunction Drugs Revenue Market Share by Countries in 2019
Figure 73. Brazil Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020) (M Pill)
Figure 74. Argentina Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020) (M Pill)
Figure 75. Middle East and Africa Erectile Dysfunction Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Erectile Dysfunction Drugs Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Erectile Dysfunction Drugs Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Erectile Dysfunction Drugs Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020) (M Pill)
Figure 80. Egypt Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020) (M Pill)
Figure 81. Turkey Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020) (M Pill)
Figure 82. South Africa Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020) (M Pill)
Figure 83. Global Erectile Dysfunction Drugs Sales and Growth Rate (2021-2025) (M Pill)
Figure 84. Global Erectile Dysfunction Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Erectile Dysfunction Drugs Market Forecast (2021-2025) (M Pill)
Figure 86. Europe Sales Erectile Dysfunction Drugs Market Forecast (2021-2025) (M Pill)
Figure 87. Asia-Pacific Sales Erectile Dysfunction Drugs Market Forecast (2021-2025) (M Pill)
Figure 88. South America Sales Erectile Dysfunction Drugs Market Forecast (2021-2025) (M Pill)
Figure 89. Middle East & Africa Sales Erectile Dysfunction Drugs Market Forecast (2021-2025) (M Pill)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
勃起不全（ED）の世界市場（～2026年） The loss of erection can be attributed to various factors such as high blood pressure, aging, diabetes mellitus, smoking, alcoholism, depression, nerve or spinal cord damage, and low testosterone levels. The ED drugs segment led the market and accounted for almost 80% of the market share in terms of…- 勃起不全衝撃波発生器の世界市場（～2026年） Market Analysis and Insights: Global Erectile Dysfunction Shockwave Generators Market The global Erectile Dysfunction Shockwave Generators market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Erectile Dysfunction Shockwave …
- 性機能障害治療薬の世界市場（～2026年） Sexual dysfunctions include sexual disorders of men and women that can interfere with their sexual performance, leading to unsatisfied sexual intercourse. The major drugs used in this market are PDE5 inhibitors, whereas other drugs such as hormone-related and transurethral also have a presence in th…
- 性機能障害治療薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Sexual Dysfunction Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Sexual Dysfunction D…
- 泌尿生殖器治療薬の世界市場（～2026年） A medical science concerned with the study and treatment of diseases of the genital and urinary organs, especially sexually transmitted diseases. The growing prevalence of genitourinary disorders is presumed to be the high rendering impact driver of this vertical. In addition, increasing number of p…